Skip to main content
Figure 2 | Critical Care

Figure 2

From: Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial

Figure 2

Time course of plasma concentrations of presepsin and procalcitonin in patients with septic shock during ICU stay by survival status. Plasma concentrations of presepsin and procalcitonin 1, 2 or 7 days after enrollment in decedents (n = 34, black) and survivors (n = 40, gray) with septic shock at ICU discharge. Data are shown as median and interquartile range. Two-way ANOVA for repeated measurements was done on log-transformed biomarker concentrations. **P < 0.001, *P = 0.007 by Mann–Whitney U test.

Back to article page